The session titled “AI in Healthcare: Navigating Innovation, Ethics, and Regulatory Compliance” brought together leading clinicians and AI researchers to examine the responsible integration of artificial intelligence in healthcare. Organised by UiT The Arctic University of Norway and featuring the Founder of Spermotile, the high-profile discussion formed a key part of the AI Impact Summit 2026.
Distinguished Panel of Clinical and AI Experts
Prof. Dilip K. Prasad from UiT The Arctic University of Norway moderated the session, while Dr. Arif Ahmed Sekh introduced the discussion and set the context for the deliberations.
The interdisciplinary panel included:
- Dr. Kiran D. Sekhar, Medical Director, Kiran Infertility Center
- Dr. Tanuj Bhatia, Professor & Head and Director – Clinical Trials & Research, SGRR Medical College & SMI Hospital
- Dr. Swarupa Mitra, Director & Unit Head, Radiation Oncology, Fortis Medical
- Dr. Gunjan Gupta Govil, Founder, Gunjan IVF World
Together, the panelists represented diverse domains, including reproductive medicine, oncology, clinical research, and AI-driven healthcare innovation.
Balancing Innovation with Ethics and Regulation
As per the press release, during the discussion, speakers emphasized that while AI offers transformative potential, healthcare systems must adopt it responsibly. They stressed that clinical validation, ethical safeguards, regulatory trust, and continuous human oversight must remain central to AI implementation.
Moreover, the panel highlighted that healthcare institutions should integrate AI tools only after rigorous testing and transparent governance frameworks. By doing so, they can protect patient safety while maintaining public trust.
Driving Global Collaboration in AI for Health
In addition to regulatory and ethical considerations, the session spotlighted international collaboration as a key enabler of progress. The speakers discussed upcoming initiatives such as the AI4Fertility workshop in Tromsø, Norway, which aims to foster cross-border knowledge exchange and innovation in reproductive health technologies.
Such collaborative platforms, they noted, will accelerate responsible AI development while ensuring alignment with global clinical standards.
Strong Engagement and Clear Takeaways
The session witnessed active audience participation, reflecting strong interest in AI’s expanding role in healthcare. Ultimately, the discussion reinforced the need for interdisciplinary collaboration among clinicians, technologists, researchers, and policymakers.
By combining innovation with accountability, the panel concluded, the healthcare ecosystem can harness AI to deliver meaningful societal value while upholding trust, safety, and clinical rigor.